Early β-blocker use and in-hospital mortality in patients with Takotsubo cardiomyopathy

Heart

Volumn 102, Issue 13, 2016, Pages 1029-1035

  Isogai, Toshiaki ^a,b   Matsui, Hiroki ^a   Tanaka, Hiroyuki ^b   Fushimi, Kiyohide ^c   Yasunaga, Hideo ^a  

^a UNIVERSITY OF TOKYO   (Japan)

^b TOKYO METROPOLITAN TAMA MEDICAL CENTER   (Japan)

^c TOKYO MEDICAL AND DENTAL UNIVERSITY   (Japan)

Author keywords

[No Author keywords available]

Indexed keywords

BISOPROLOL; CARVEDILOL; ESMOLOL; LANDIOLOL; PROPRANOLOL; BETA ADRENERGIC RECEPTOR BLOCKING AGENT;

AGED; ARTICLE; COHORT ANALYSIS; CONTROLLED STUDY; FEMALE; HOSPITAL ADMISSION; HOSPITAL MORTALITY; HOSPITALIZATION; HUMAN; JAPAN; MAJOR CLINICAL STUDY; MALE; PRIORITY JOURNAL; PROPENSITY SCORE; RETROSPECTIVE STUDY; TAKOTSUBO CARDIOMYOPATHY; TREATMENT DURATION; CLINICAL TRIAL; DRUG ADMINISTRATION; EPIDEMIOLOGY; FACTUAL DATABASE; MIDDLE AGED; MORTALITY; MULTICENTER STUDY; VERY ELDERLY;

ADRENERGIC BETA-ANTAGONISTS; AGED; AGED, 80 AND OVER; DATABASES, FACTUAL; DRUG ADMINISTRATION SCHEDULE; FEMALE; HOSPITAL MORTALITY; HOSPITALIZATION; HUMANS; JAPAN; MALE; MIDDLE AGED; PROPENSITY SCORE; RETROSPECTIVE STUDIES; TAKOTSUBO CARDIOMYOPATHY;

EID: 84959267468     PISSN: 13556037     EISSN: 1468201X     Source Type: Journal    
DOI: 10.1136/heartjnl-2015-308712     Document Type: Article

References (30)

1. Ghadri JR, Ruschitzka F, L scher TF, et al. Takotsubo cardiomyopathy: still much more to learn. Heart. 2014; 100: 1804-12.
2. Prasad A, Lerman A, Rihal CS. Apical ballooning syndrome (Tako-Tsubo or stress cardiomyopathy): a mimic of acute myocardial infarction. Am Heart J. 2008; 155: 408-17.
3. Kurisu S, Kihara Y. Clinical management of Takotsubo cardiomyopathy. Circ J. 2014; 78: 1559-66.
4. Akashi YJ, Goldstein DS, Barbaro G, et al. Takotsubo cardiomyopathy: a new form of acute, reversible heart failure. Circulation. 2008; 118: 2754-62.
5. Yoshikawa T. Takotsubo cardiomyopathy, a new concept of cardiomyopathy: clinical features and pathophysiology. Int J Cardiol. 2014; 182C: 297-303.
6. Templin C, Ghadri JR, Diekmann J, et al. Clinical features and outcomes of Takotsubo (stress) cardiomyopathy. N Engl J Med. 2015; 373: 929-38.
7. Isogai T, Yasunaga H, Matsui H, et al. Out-of-hospital versus in-hospital Takotsubo cardiomyopathy: analysis of 3719 patients in the Diagnosis Procedure Combination database in Japan. Int J Cardiol. 2014; 176: 413-7.
8. Brinjikji W, El-Sayed AM, Salka S. In-hospital mortality among patients with takotsubo cardiomyopathy: a study of the National Inpatient Sample 2008 to 2009. Am Heart J. 2012; 164: 215-21.
9. Murakami T, Yoshikawa T, Maekawa Y, et al. Characterization of predictors of in-hospital cardiac complications of takotsubo cardiomyopathy: multi-center registry from Tokyo CCU Network. J Cardiol. 2014; 63: 269-73.
10. Schneider B, Athanasiadis A, Schwab J, et al. Complications in the clinical course of tako-Tsubo cardiomyopathy. Int J Cardiol. 2014; 176: 199-205.
11. Redfors B, Vedad R, Angerås O, et al. Mortality in takotsubo syndrome is similar to mortality in myocardial infarction-A report from the SWEDEHEART registry. Int J Cardiol. 2015; 185: 282-9.
12. Elesber AA, Prasad A, Lennon RJ, et al. Four-year recurrence rate and prognosis of the apical ballooning syndrome. J Am Coll Cardiol. 2007; 50: 448-52.
13. McMurray JJ, Adamopoulos S, Anker SD, et al. ESC guidelines for the diagnosis and treatment of acute and chronic heart failure 2012: The Task Force for the Diagnosis and Treatment of Acute and Chronic Heart Failure 2012 of the European Society of Cardiology. Developed in collaboration with the Heart Failure Association (HFA) of the ESC. Eur J Heart Fail. 2012; 14: 803-69.
14. Steg PG, James SK, Atar D, et al. ESC Guidelines for the management of acute myocardial infarction in patients presenting with ST-segment elevation. Eur Heart J. 2012; 33: 2569-619.
15. Amsterdam EA, Wenger NK, Brindis RG, et al. 2014 AHA/ACC guideline for the management of patients with non-ST-elevation acute coronary syndromes: a report of the American College of Cardiology/American Heart Association Task Force on Practice Guidelines. Circulation. 2014; 130: e344-426.
16. Chen ZM, Pan HC, Chen YP, et al. Early intravenous then oral metoprolol in 45, 852 patients with acute myocardial infarction: randomised placebo-controlled trial. Lancet. 2005; 366: 1622-32.
17. Mehta RH, Starr AZ, Lopes RD, et al. Incidence of and outcomes associated with ventricular tachycardia or fibrillation in patients undergoing primary percutaneous coronary intervention. JAMA. 2009; 301: 1779-89.
18. Kumar S, Kaushik S, Nautiyal A, et al. Cardiac rupture in takotsubo cardiomyopathy: a systematic review. Clin Cardiol. 2011; 34: 672-6.
19. Redfors B, Shao Y, Ali A, et al. Current hypotheses regarding the pathophysiology behind the takotsubo syndrome. Int J Cardiol. 2014; 177: 771-9.
20. Wittstein IS, Thiemann DR, Lima JA, et al. Neurohumoral features of myocardial stunning due to sudden emotional stress. N Engl J Med. 2005; 352: 539-48.
21. Akashi YJ, Nef HM, Lyon AR. Epidemiology and pathophysiology of Takotsubo syndrome. Nat Rev Cardiol. 2015; 12: 387-97.
22. Madhavan M, Borlaug BA, Lerman A, et al. Stress hormone and circulating biomarker profile of apical ballooning syndrome (Takotsubo cardiomyopathy): insights into the clinical significance of B-Type natriuretic peptide and troponin levels. Heart. 2009; 95: 1436-41.
23. Paur H, Wright PT, Sikkel MB, et al. High levels of circulating epinephrine trigger apical cardiodepression in a beta2-Adrenergic receptor/Gi-dependent manner: a new model of Takotsubo cardiomyopathy. Circulation. 2012; 126: 697-706.
24. Austin PC. A critical appraisal of propensity-score matching in the medical literature between 1996 and 2003. Stat Med. 2008; 27: 2037-49.
25. Bateman BT, Bykov K, Choudhry NK, et al. Type of stress ulcer prophylaxis and risk of nosocomial pneumonia in cardiac surgical patients: cohort study. BMJ. 2013; 347: f5416
26. Brookhart MA, Rassen JA, Schneeweiss S. Instrumental variable methods in comparative safety and effectiveness research. Pharmacoepidemiol Drug Saf. 2010; 19: 537-54.
27. Fazio G, Pizzuto C, Barbaro G, et al. Chronic pharmacological treatment in takotsubo cardiomyopathy. Int J Cardiol. 2008; 127: 121-3.
28. Palla AR, Dande AS, Petrini J, et al. Pretreatment with low-dose beta-Adrenergic antagonist therapy does not affect severity of Takotsubo cardiomyopathy. Clin Cardiol. 2012; 35: 478-81.
29. Neil C, Nguyen TH, Kucia A, et al. Slowly resolving global myocardial inflammation/.oedema in Tako-Tsubo cardiomyopathy: evidence from T2-weighted cardiac MRI. Heart. 2012; 98: 1278-84.
30. Dawson DK, Neil CJ, Henning A, et al. Tako-Tsubo cardiomyopathy: a heart stressed out of energy? JACC Cardiovasc Imaging. 2015; 8: 985-7.